BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019

Mar 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-03-15

Reporting Person: Mueller Brian (SVP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-15	Common Stock	F	1149	$94.53	Disposed	11248	Direct
2019-03-15	Common Stock	A	5780	—	Acquired	17028	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-15	Stock Option (Right to buy Common Stock)	$94.53	A	9650	Acquired	2029-03-14	Common Stock (9650)	Direct

Footnotes

F1: Restricted stock units granted on March 15, 2019. Price not applicable.

F2: Option grant vests 12/48th on March 15, 2020 and 1/48th on the 15th day of each month thereafter.